Sort   by:  
 Page size 
TranscriptomicsTranscriptional profiling of clinically relevant SERMs and SERM/estradiol complexes in a cellular model of breast cancer
In this study, we have utilized microarray analysis to directly compare a subset of structurally distinct, clinically relevant SERMs in the presence and absence of estradiol, using a high replicate number (10) to ensure detection of modestly regulated genes. Tested compounds included 4-hydroxytamoxi...
ORGANISM(S): Homo sapiens 
2012-05-08 | E-GEOD-35428 | biostudies-arrayexpress
UnknownMutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.
Not available
S-EPMC6485456 | biostudies-literature
TranscriptomicsGenotyping by array of anaplastic oligodendroglioma
A Cartes d'Identite des Tumeurs (CIT) project from the french Ligue Nationale Contre le Cancer (http://cit.ligue-cancer.net: Anaplastic oligodendrogliomas (AOs) are rare primary brain tumors which are generally incurable with few treatment targets identified. Most oligodendrogliomas have chromosome ...
ORGANISM(S): Homo sapiens 
2015-07-23 | E-MTAB-3457 | biostudies-arrayexpress
TranscriptomicsRecurrent TCF12 mutations in anaplastic oligodendroglioma (Part II, genotyping by array)
A Cartes d'Identite des Tumeurs (CIT) project from the french Ligue Nationale Contre le Cancer (http://cit.ligue-cancer.net); Anaplastic oligodendrogliomas (AOs) are rare primary brain tumors which are generally incurable with few treatment targets identified. Most oligodendrogliomas have chromosome...
ORGANISM(S): Homo sapiens 
2015-06-15 | E-MTAB-2771 | biostudies-arrayexpress
UnknownHealing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition.
Not available
S-EPMC12372396 | biostudies-literature
UnknownSearch for rare protein altering variants influencing susceptibility to multiple myeloma.
Not available
S-EPMC5482649 | biostudies-literature
UnknownHSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target.
Not available
S-EPMC6420136 | biostudies-literature
UnknownStructural variants shape the genomic landscape and clinical outcome of multiple myeloma.
Not available
S-EPMC9151656 | biostudies-literature
Genomicsena-DATASET-ICR-GM-05-05-2015-22:13:47:053-131 - samples
463 newly diagnosed patients from the UK Myeloma XI clinical trial (NCT01554852) underwent whole exome sequencing plus targeted capture of the IGH/K/L and MYC loci. 200 ng of DNA were processed using NEBNext DNA library prepartion kit and hybridised to the SureSelect Human All Exon V5 Plus. Four s...
EGAD00001001358 | EGA
Genomics463 newly diagnosed patients with Multiple Myeloma underwent whole exome sequencing of tumour and peripheral blood DNA.
463 newly diagnosed patients from the UK Myeloma XI clinical trial (NCT01554852) underwent whole exome sequencing plus targeted capture of the IGH/K/L and MYC loci. 200 ng of DNA were processed using NEBNext DNA library prepartion kit and hybridised to the SureSelect Human All Exon V5 Plus. Four s...
EGAS00001001147 | EGA
Sort   by:  
 Page size